Displaying items by tag: novartis

The acquisition of Regulus Therapeutics, a California-based biotechnology company focused on microRNA therapies, by Novartis for $1.7 billion was a major strategic move to expand the latter’s research portfolio in RNA technology.

The revelations that have been coming to light lately about the SYRIZA government are a topic in the international media. In fact, France 24 and the New York Times, respectively, refer to the recent revelations about the attempt to cover up the Mati fire and the Novartis conspiracy.

An investigation into the handling of a controversial judicial investigation that pointed to the alleged bribery of Greek politicians by Swiss pharmaceuticals firm Novartis got under way on Tuesday with the testimony of the country's top corruption prosecutor Eleni Touloupaki.